Valneva SE VALN

Updated: 8 Aug 2026

NASDAQ | Biotech | Biotechnology and vaccines

No signal published yet

We already track Valneva SE and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Valneva SE free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and vaccines
We're already tracking Valneva SE — here are the latest events we've registered

Recent News

  • On July 22, 2026, Valneva announced that it will report its financial results for the first half of 2026 on August 13, 2026. In May 2026, the company reported a first-quarter cash position of €105.3 million and highlighted ongoing progress in its Lyme disease vaccine candidate partnered with Pfizer.

What Firelda Watch includes for Valneva SE

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Valneva SE will be delivered in the same format.

Want to follow Valneva SE? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Valneva SE free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Valneva SE VALN
Valneva SE — follow and we'll monitor it
Follow Valneva SE free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.